VITRAKVI (LAROTRECTINIB)

**Product type:** Human Prescription Drug

**Active ingredient:** LAROTRECTINIB

**Strength:** 20 mg/mL

**Dosage form:** Solution

**Route:** Oral

**Labeler:** Loxo Oncology, Inc.

**Marketing category:** NDA (NDA211710)

**Pharmacologic class:** Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]